Login / Signup

Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial.

Steven McKinstryJanine PilcherGeorge BardsleyJames BerrySusanne Van de HeiIrene BraithwaiteJames FingletonMark WeatherallRichard Beasley
Published in: Respirology (Carlton, Vic.) (2017)
NHF results in a small flow-dependent reduction in PtCO2 and respiratory rate in patients with stable COPD.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • cystic fibrosis
  • air pollution
  • stem cells
  • open label
  • mesenchymal stem cells
  • cell therapy